Author:
Kupershmidt Lana,Amit Tamar,Bar-Am Orit,Youdim Moussa B.H.,Weinreb Orly
Funder
Alzheimer's Association (Chicago, USA)
Technion-Research and Development and Rappaport Family Research Institute, Technion-Israel Institute of Technology (Haifa, Israel)
Subject
Developmental Biology,Ageing
Reference67 articles.
1. Targeting multiple Alzheimer's disease etiologies with multimodal neuroprotective and neurorestorative iron chelators;Amit;FASEB J.,2008
2. Therapeutic targets and potential of the novel brain- permeable multifunctional iron chelator-monoamine oxidase inhibitor drug, M-30, for the treatment of Alzheimer's disease;Avramovich-Tirosh;J. Neurochem.,2007
3. Neurorescue activity, APP regulation and amyloid-beta peptide reduction by novel multi-functional brain permeable iron-chelating-antioxidants, M-30 and green tea polyphenol, EGCG;Avramovich-Tirosh;Curr. Alzheimer Res.,2007
4. Physiological and pathological aspects of Abeta in iron homeostasis via 5′UTR in the APP mRNA and the therapeutic use of iron-chelators;Avramovich-Tirosh;BMC Neurosci.,2008
5. Up-regulation of hypoxia-inducible factor (HIF)-1alpha and HIF-target genes in cortical neurons by the novel multifunctional iron chelator anti-alzheimer drug, M30;Avramovich-Tirosh;Curr. Alzheimer Res.,2010
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献